Exchanges At Goldman Sachs
Vaccine Progress and What’s Next
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:09:56
- More information
Informações:
Synopsis
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
